Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Indrayani Hospital And Cancer Institute

Verified

Basic Information

Site Overview

Source: Human-provided.

Indrayani Hospital & Cancer Institute, established by the Shree Narsimha Saraswati Medical Foundation, is a well-recognized cancer care centre located on Alandi-Chakan Road in Pune, Maharashtra, India. The hospital focuses on delivering affordable and comprehensive cancer treatment to patients from diverse socio-economic backgrounds, making quality oncology care accessible across the region. It offers multidisciplinary cancer services including medical oncology (chemotherapy & immunotherapy), radiation oncology, surgical oncology and pediatric oncology, supported by advanced diagnostics and therapy facilities under one roof. The centre emphasizes standardized treatment protocols, supportive care and personalised patient guidance, helping individuals at various stages of cancer management. As a charitable institution, Indrayani also participates in community outreach and government health schemes to extend care to underserved populations, reinforcing its mission to reduce financial…

Source: Trial-derived.
6Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
3Active Trials
Source: Trial-derived.
3Completed Trials
Source: Trial-derived.
8Unique Conditions
Source: Trial-derived.
7Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. AIDS-related Kaposi Sarcoma (1)Source: Trial-derived. Metastatic Breast Cancer (1)Source: Trial-derived. Multiple Myeloma (1)Source: Trial-derived. Non-muscle Invasive Bladder Cancer (1)Source: Trial-derived. Ovarian Cancer (1)Source: Trial-derived. Squamous Cell Carcinoma of Oral Cavity (1)Source: Trial-derived. Thyroid Neoplasms (1)

Sponsors

Source: Trial-derived. Tolmar Inc. (2)Source: Trial-derived. Baxter Healthcare Corporation (1)Source: Trial-derived. Eisai Pharmaceuticals India Pvt. Ltd (1)Source: Trial-derived. Grant Medical Foundation Ruby hall Clinic (1)Source: Trial-derived. ImmunityBio, Inc. (1)Source: Trial-derived. Indrayani Hospital and Cancer Institute (1)Source: Trial-derived. Tata Capital Limited (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Dedicated Phase 1 Unit

Source: Human-provided. Yes

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 25

Principal investigators

Source: Human-provided. 5

Study coordinators

Source: Human-provided. 20

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom